Hypericins as potential leads for new therapeutics

International Journal of Molecular Sciences

Volumn 11, Issue 2, 2010, Pages 562-594

  Karioti, Anastasia ^a   Bilia, Anna Rita ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antidepressant; Antiviral; Hypericin; Hypericum perforatum; Naphthodianthrones; Photodynamic therapy; Pseudohypericin

Indexed keywords

AMINOLEVULINIC ACID; CELECOXIB; CISPLATIN; EMODIN; HYPERICIN; INDOMETACIN; NAPHTHODIANTHRONE DERIVATIVE; PHOTOSENSITIZING AGENT; POLYPHENOL DERIVATIVE; PSEUDOHYPERICIN; UNCLASSIFIED DRUG;

ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER THERAPY; CELL SURVIVAL; COMPETITIVE INHIBITION; DEPRESSION; DRUG ISOLATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOPHYTE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERICUM PERFORATUM; METASTASIS INHIBITION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; PHOTOACTIVATION; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; RETINOPATHY; REVIEW; SOXHLET EXTRACTION; SUPERCRITICAL FLUID EXTRACTION; ULTRAVIOLET A RADIATION;

ANTIDEPRESSANT; ANTIVIRAL; HYPERICIN; HYPERICUM PERFORATUM; NAPHTHODIANTHRONES; PHOTODYNAMIC THERAPY; PSEUDOHYPERICIN;

ANTI-INFECTIVE AGENTS; ANTIDEPRESSIVE AGENTS; CELL SURVIVAL; HUMANS; HYPERICUM; NEOPLASMS; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

HYPERICUM PERFORATUM;

EID: 77649229910     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms11020562     Document Type: Review

References (160)

1. Brockmann, H.; Haschad, M.N.; Maier, K.; Pohl, F. Hypericin, the photodynamically active pigment from Hypericum perforatum. Naturwissenschaften 1939, 32, 550.
2. Brockmann, H.; Sanne, W. Pseudohypericin, a new red Hypericum pigment. Naturwissenschaften 1953, 40, 461.
3. Cameron, D.W.; Raverty, W.D. Pseudohypericin and other phenanthroperylene quinones. Aus. J. Chem. 1976, 29, 1523-1533.
4. AHP. American Herbal Pharmacopoeia; Upton, R., Ed.; St. John's Wort (Hypericum perforatum): Santa Cruz, CA, USA, 1997; pp. 1-32.
5. Wichtl, M. Teedrogen: ein Handbuch fur dir Praxis auf wissenschaftlicher Grundlage. Wissenschaftliche Verlagsgesellschaft mbH: Stuttgart, Germany, 1989.
6. EP. European Pharmacopoeia, 6th ed.; Council of Europe: Strasbourg, France, 2008; Volume 2, p. S2958.
7. Bruni, R.; Sacchetti, G. Factors affecting polyphenol biosynthesis in wild and field grown St. John's Wort (Hypericum perforatum L. Hypericaceae/Guttiferae). Molecules 2009, 14, 682-725.
8. Zobayed, S.M.A.; Afreen, F.; Goto, E.; Kozai. T. Plant-Environment Interactions: Accumulation of hypericin in dark glands of Hypericum perforatum. Ann. Bot. 2006, 98, 793-804.
9. Poutaraud, A.; Di Gregorio, F.; Chan Fook Tin, V.; Girardin, P. Effect of light on hypericins contents in fresh flowering top parts and in an extract of St John's Wort (Hypericum perforatum). Planta Med. 2001, 67, 254-259.
10. Wirz, A.; Meier, B.; Sticher, O. Stability of hypericin and pseudohypericin in extract solutions of Hypericum perforatum and in standard solutions. Pharm. Ind. 2001, 63, 410-415.
11. Williams, F.B.; Lane, C.; Sander, L.C.; Wise, S.A; Girard, J. Development and evaluation of methods for determination of naphthodianthrones and flavonoids in St. John's wort. J. Chromatogr. A 2006, 1115, 93-102.
12. Mauri, P; Pietta, P. High performance liquid chromatography/electrospray mass spectrometry of Hypericum perforatum extracts. Rapid Commun. Mass Spectrom. 2000, 14, 95-99.
13. Crockett, S.L.; Schaneberg, B.; Khan, I.A. Phytochemical profiling of new and old world Hypericum (St. John's wort) species. Phytochem. Anal. 2005, 16, 479-485.
14. Kitanov, M.K. Hypericin and pseudohypericin in some Hypericum species. Biochem. Syst. Ecol. 2001, 29, 171-178.
15. Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach, 2 ed.; Jonh Wiley & sons: Baffins Lane, Chichester, West Sussex, UK, 2002; p. 67.
16. Kusari, S.; Zuhlke, S.; Kosuth, J.; Cellarova, E.; Spiteller, M. Light-independent metabolomics of endophytic Thielavia subthermophila provides insight into microbial hypericin biosynthesis. J. Nat. Prod. 2009, 72, 1825-1835.
17. Kusari, S; Lamshöft, M; Zühlke, S; Spiteller, M. An endophytic fungus from Hypericum perforatum that produces hypericin. J. Nat. Prod. 2008, 71, 159-162.
18. Chen, Z.G.; Fujii, I.; Ebizuka, Y.; Sankawa, U. Purification and characterization of emodinanthrone oxygenase from Aspergillus terreus. Phytochemistry 1995, 38, 299-305.
19. Karppinen, K.; Hohtola, A. Molecular cloning and tissue-specific expression of two cDNAs encoding polyketide synthases from Hypericum perforatum. J. Plant Physiol. 2008, 165, 1079-1086.
20. Bais, H.P.; Vepachedu, R.; Lawrence, C.B.; Stermitz, F.R.; Vivanco, J.M. Molecular and biochemical characterization of an enzyme responsible for the formation of hypericin in St. John's Wort (Hypericum perforatum L.). J. Biol. Chem. 2003, 278, 32413-32422.
21. Kosuth, J.; Katkovcinova, Z.; Olexova, P.; Cellarova, E. Expression of the hyp-1 gene in early stages of development of Hypericum perforatum L. Plant Cell. Rep. 2007, 26, 211-217.
22. Etzlstorfer, C.; Falk, H.; Müller, N.; Schmitzberger, W.; Wagner, U.G. Tautomerism and stereochemistry of hypericin: Force field, NMR, and X-ray crystallographic investigations. Monatsh. Chemie 1993, 124, 751-761.
23. Gutman, I.; Marković, Z.; Solujić, S.; Sukdolak, S. On the tautomers of hypericin. Monatsh. Chemie 1998, 129, 481-486.
24. Kapinus, E.I.; Falk, H.; Tran, H.T.N. Spectroscopic investigation of the molecular structure of hypericin and its Salts. Monatsh. Chemie 1999, 130, 623-635.
25. Falk, H.; Meyer, J. On the homo- and heteroassociation of hypericin. Monatsh. Chemie 1994, 125, 753-762.
26. Falk, H.; Schmitzberger, W. On the nature of "Soluble" hypericin in Hypericum species. Monatsh. Chemie 1992, 123, 731-739.
27. Etzlstorfer, C.; Falk, H..; Müller, N.; Tran, T.N.H. Structural aspects and electronic absorption of the hydroxyphenanthroperylene quinones fringlit D, hypericin, and stentorin. Monatsh. Chemie 1996, 127, 659-668.
28. Shen, L.; Ji H.F.; Zhang, H.Y. Anion of hypericin is crucial to understanding the photosensitive features of the pigment. Bioorg. Med. Chem. Lett. 2006, 16, 1414-1417.
29. Gai, F., Fehr, M.J.; Petrich, J.W. Observation of excited-state tautomerization in the antiviral agent hypericin and identification of its fluorescent species. J. Phys. Chem. 1994, 98, 5184-5195.
30. English, D.S.; Zhang, W.; Kraus, G.A.; Petrich. J.W. Excited-state photophysics of hypericin and its hexamethoxy analog: intramolecular proton transfer as a nonradiative process in hypericin. J. Am. Chem. Soc. 1997, 119, 2980-2986.
31. Wirz, A.; Meier, B.; Sticher, O. Solubility of hypericin in methanol and methanol-pyridine. Pharmazie 2002, 57, 543-545.
32. Butterweck, V.; Petereit, F; Winterhoff, H. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med. 1998, 64, 291-294.
33. Miskovsky, P. Hypericin-A new antiviral and antitumor photosensitizer: Mechanism of action and interaction with biological macromolecules. Curr. Drug Targets 2002, 3, 55-84.
34. Brolis, M.; Gabetta, B.; Fuzzati, N.; Pace, R.; Panzeri, F.; Peterlongo, F. Identification by high-performance liquid chromatography-diode array detection-mass spectrometry and quantification by high-performance liquid chromatography-UV absorbance detection of active constituents of Hypericum perforatum. J. Chromatogr. A 1998, 825, 9-16.
35. Maisenbacher, P.; Kovar, K.A. Analysis and stability of Hyperici oleum. Planta Med. 1992, 58, 351-354.
36. Wirz, A.; Meier, B.; Sticher, O. Stability of hypericin and pseudohypericin in extract solutions of Hypericum perforatum and in standard solutions. Pharm. Ind. 2001, 63, 410-415.
37. Liu, F.; Pan, C.; Drumm, P.; Ang. C.Y.W. Liquid chromatography-mass spectrometry studies of St. John's wort methanol extraction: Active constituents and their transformation. J. Pharm. Biomed. Anal. 2005, 37, 303-312.
38. Fourneron, J.D.; Herbette, G.; Caloprisco, E. Pseudohypericin and hypericin in St. John's wort extracts. C. R. Acad. Sc. Série II 1999, 127-131.
39. Fourneron, J.D.; Naït-Si, Y.; Rosas, R.; Faure, R.; Viant, P. Identification of isopseudohypericin, a new phenanthroperylene quinone obtained by the alkaline treatment of pseudohypericin. Tetrahedron Lett. 2003, 44, 6285-6288.
40. Karioti, A.; Vincieri, F.F.; Bilia, A.R. Rapid and efficient purification of naphthodianthrones from St. John's Wort extract by using liquid-liquid extraction and size exclusion column chromatography. J. Sep. Sci. 2009, 32, 1374-1382.
41. Ang, C.Y.W.; Cui, Y.; Chang, H.C.; Lou, W.; Heinze, T.M.; Lin L.J.; Mattia, A. Determination of St. John's Wort components in dietary supplements and functional foods by liquid chromatography. J. AOAC Int. 2002, 85, 1360-1369.
42. Draves, A.H.; Walker, S.E. Determination of hypericin and pseudohypericin in pharmaceutical preparations by liquid chromatography with fluorescence detection. J. Chromatogr. B 2000, 749, 1057-1066.
43. Smelcerovic, A.; Spiteller, M.; Zuehlke, S. Comparison of methods for the exhaustive extraction of hypericins, flavonoids, and hyperforin from Hypericum perforatum L. J. Agric. Food Chem. 2006, 54, 2750-2753.
44. Benthin, B.; Danz, H.; Hamburger, M. Pressurized liquid extraction of medicinal plants. J. Chromatogr. A 1999, 837, 211-219.
45. Catchpole, O.J.; Perry, N.B.; da Silva, B.M.T.; Grey, J.B.; Smallfield, B.M. Supercritical extraction of herbs I: Saw Palmetto, St John's Wort, Kava Root, and Echinacea. J. Supercrit. Fluids 2002, 22, 2129-2138.
46. Tolonen, A.; Uusitalo, J.; Hohtola, A.; Jalonen, J. Determination of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2002, 16, 396-402.
47. Kubin, A.; Alth, G.; Jindra, R.; Jessner, G.; Ebermann, R. Wavelength-dependent photoresponse of biological and aqueous model systems using the photodynamic plant pigment hypericin. J. Photochem. Photobiol. B 1996, 36, 103-108.
48. Kacerovskà, D.; Pizinger, K.; Majer, F.; Śmíd, F. Photodynamic therapy of non melanoma skin cancer with topical Hypericum perforatum extract-A pilot study. Photochem. Photobiol. 2008, 84, 779-785.
49. Sattler, S.; Schaefer, U.; Schneider, W.; Hoelzl, J.; Lehr, C.M. Binding, uptake, and transport of hypericin by Caco-2 cell monolayers. J. Pharm. Sci. 1997, 86, 1120-1126.
50. Vandenbogaerde, A.L.; Kamuhabwa, A.; Delaey, E.; Himpens, B.E.; Merlevede, W.J.; de Witte, P.A. Photocytotoxic effect of pseudohypericin versus hypericin. J. Photochem. Photobiol. B 1998, 45, 87-94.
51. Butterweck, V.; Christoffel, V.; Nahrstedt, A.; Petereit, F.; Spengler, B.; Winterhoff, H. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioural models. Life Sci. 2003, 73, 627-639.
52. Smelcerovic, A.; Laatsch, H.; Lepojevic, Z.; Djordjevic, S. The separation of hypericin and pseudohypericin from Hypericum perforatum L. Pharmazie 2002, 57, 178-180.
53. Wirz, A. Analytical and phytochemical investigations on hypericin and related compounds of Hypericum perforatum. Thesis No. 13553, ETH Zurich, Switzerland, 2000.
54. Brockmann, H.; Kluge, F.; Muxfeldt, H. Totalsynthese des hypericins. Chem. Ber. 1957, 90, 2302-2318.
55. Brockmann, H.; Kluge, F. The synthesis of hypericin. Naturwissenschaften 1951, 38, 141.
56. Falk, H.; Meyer, J.; Oberreiter, M. A convenient semistynthetic route to hypericin. Monatsh. Chemie 1993, 124, 339-341.
57. Falk, H.; Schoppel, G.A. Synthesis of emodin anthrone. Monatsh. Chemie 1991, 122, 739-744.
58. Aigner, S.; Falk, H. A microwave-assisted synthesis of phenanthroperylene quinones as exemplified with hypericin. Monatsh. Chemie 2008, 139, 991-993.
59. Motoyoshiya, J.; Masue, Y.; Nishi, Y.; Aoyama, H. Synthesis of hypericin via emodin anthrone derived from a two-fold Diels-Alder reaction of 1,4-benzoquinone. Nat. Prod. Commun. 2007, 2, 67-70.
60. Lackner, B.; Popova, Y.; Etzlstorfer, C.; Smelcerovic, A.A.; Klampfl, C.W.; Falk, H. Syntheses and Properties of Two Heterocyclically Substituted Hypericin Derivatives: 10,11-Dibenzothiazolyl-10,11-didemethylhypericin and 10,11-Dibenzoxazolyl-10,11-didemethylhypericin. Monatsh. Chemie 2005, 136, 777-793.
61. Waser, M.; Popova, Y.; Klampfl, C.W.; Falk, H. 9,12- Dibenzothiazolylhypericin and 10,11-Dibenzothiazolyl-10,11-didemethylhypericin: Photochemical properties of hypericin derivatives depending on the substitution site. Monatsh. Chemie 2005, 136, 1791-1797.
62. Lackner, B.; Bretterbauer, K.; Schwarzinger, C.; Falk, H. A route to amino functionalized hypericin derivatives and their chemical and photochemical properties pertaining to photodynamic therapy. Monatsh. Chemie 2005, 136, 2067-2082.
63. Waser, M.; Falk, H. Condensed emodin derivatives and their applicability for the synthesis of a fused heterocyclic hypericin derivative. Eur. J. Org. Chem. 2006, 1200-1206.
64. Zuschrader, J.; Reiter, G.; Falk, H. ω,ω′ -Urea- and -dithioacetal-derivatives of hypericin. Monatsh. Chemie 2008, 139, 995-998.
65. Aigner, S.; Falk, H. On synthesis and properties of hypericin-porphyrin hybrids. Monatsh. Chemie 2008, 139, 1513-1518.
66. Geisslmeir, D.; Falk, H. ω,ω′-Appended nucleo-base derivatives of hypericin. Monatsh. Chemie 2008, 139, 1127-1136.
67. Crnolatac, I.; Huygens, A.; van Aerschot, A.; Busson, R.; Rozenski, J.; de Witte, P.A.M. Synthesis, in vitro cellular uptake and photo-induced antiproliferative effects of lipophilic hypericin acid derivatives. Bioorg. Med. Chem. 2005, 13, 6347-6353.
68. Kim, S.W.; Park, J.H.; Yang, S.D.; Hur, M.G.; Choi, C.W.; Yu, K.H. Synthesis and in vitro/vivo evaluation of iodine-123/124 labelled hypericin derivatives. Bull. Korean Chem. Soc. 2008, 29, 2023-2025.
69. Fonge, H.; Jin, L.; Wang, H.; Bormans, G.; Ni, Y.; Verbruggen, A. Synthesis and preliminary biological evaluation of a 99mTc-labeled hypericin derivative as a necrosis avid imaging agent. J. Labelled Comp. Rad. 2008, 51, 33-40.
70. Zuschrader, J.; Schoefberger, W.; Falk, H. A carbohydrate-linked hypericinic photosensitizing agent. Monatsh. Chemie 2008, 139, 1387-1390.
71. Hager, B.; Strauss, W.S.L.; Falk, H. Cationic hypericin derivatives as novel Agents with photobactericidal activity: Synthesis and photodynamic inactivation of Propionibacterium acnes. Photochem. Photobiol. 2009, 85, 1201-1206.
72. Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 2004, 1, 279-293.
73. Castano, A.P.; Demidova, T.N.; Hamblin, M.R. Mechanisms in photodynamic therapy: Part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2005, 2, 1-23.
74. Vandenbogaerde, A.L.; Kamuhabwa, A.; Delaey, E.; Himpens, B.E.; Merlevede, W.J.; de Witte, P.A. Photocytotoxic effect of pseudohypericin versus hypericin. J. Photochem. Photobiol. B 1998, 45, 87-94.
75. Thomas, C.; MacGill, R.S.; Miller, G.C.; Pardini, R.S. Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem. Photobiol. 1992, 55, 47-53.
76. Thomas, C.; Pardini, R.S. Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem. Photobiol. 1992, 55, 831-837.
77. Kubin, A.; Wierrani, F.; Burner, U.; Alth, G.; Grünberger, W. Hypericin-The facts about a controversial agent. Curr. Pharm. Des. 2005, 11, 233-253.
78. Agostinis, P.; Vantieghem, A.; Merlevede, W.; de Witte, P.A. Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell. Biol. 2002, 34, 221-241.
79. Davids, L.M.; Kleemann, B.; Kacerovskà, D.; Pizinger, K,; Kidson, S.H. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. J. Photochem. Photobiol. B 2008, 91, 67-76.
80. Davids, L.M.; Kleemann, B.; Cooper, S.; Kidson, S.H. Melanomas display increased cytoprotection to hypericin-mediated cytotoxicity through the induction of autophagy. Cell Biol. Int. 2009, 33, 1065-1072.
81. Kober, M.; Pohl, K.; Efferth, T. Molecular mechanisms underlying St. John's Wort drug interactions. Curr. Drug Metabol. 2008, 9, 1027-1037.
82. Schneider-Yin, X.; Kurmanaviciene, A.; Roth, M.; Roos, M.; Fedier, A.; Minder, E.I.; Walt, H. Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light. Photodiagn. Photodyn. Ther. 2009, 6, 12-18.
83. Kleban, J.; Szilardiova, B.; Mikes, J.; Horvath, V.; Sackova, V.; Brezani, P.; Hofmanova, J.; Kozubik, A.; Fedorocko, P. Pre-treatment of HT-29 cells with 5-LOX inhibitor (MK-886) induces changes in cell cycle and increases apoptosis after photodynamic therapy with hypericin J. Photochem. Photobiol. B 2006, 84, 79-88.
84. Kleban, J.; Mikes, J.; Horvath, V.; Sackova, V.; Hofmanova, J.; Kozubik, A.; Fedorocko, P. Mechanisms involved in the cell cycle and apoptosis of HT-29 cells pre-treated with MK-886 prior to photodynamic therapy with hypericin. J. Photochem. Photobiol. B 2008, 93, 108-118.
85. Robertson, C.A.; Hawkins, D.; Abrahamse, H. Photodynamic Therapy (PDT): A short review on ellular mechanisms and cancer research applications for PDT. J. Photochem. Photobiol. B 2009, 96, 1-8.
86. Lavie, G.; Mazur, Y.; Lavie, D.; Meruelo, D. The chemical and biological properties of hypericin-a compound with a broad spectrum of biological activities. Med. Res. Rev. 1995, 15, 111-119.
87. Duo, H.; Olivo, M.; Mahendran, R.; Bay, B.H. Modulation of matrix metalloproteinase-1 in nasopharyngeal cancer cells by photoactivation of hypericin. Int. J. Oncol. 2004, 24, 657-662.
88. Miccoli, L.; Beurdeley-Thomas, A.; De, P.G.; Sureau, F.; Oudard, S.; Dutrillaux, B.; Poupon, M.F. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Cancer Res. 1998, 58, 5777-5786.
89. Agostinis, P.; Assefa, Z.; Vantieghem, A.; Vandenheede, J.R.; Merlevede, W.; de Witte, P. Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin. Adv. Enzyme. Regul. 2000, 40, 157-182.
90. Mikes, J.; Kleban, J.; Sackova, V.; Horvath, V.; Jamborova, E.; Vaculova, A.; Kozubik, A.; Hofmanova, J.; Fedorocko, P. Necrosis predominates in the cell death of human colon adenocarcinoma HT-29 cells treated under variable conditions of photodynamic therapy with hypericin. Photochem. Photobiol. Sci. 2007, 6, 758-766.
91. Berlanda, J.; Kiesslich, T.; Oberdanner, C.B.; Obermair, F.J.; Krammer, B.; Plaetzer, K. Characterization of apoptosis induced by photodynamic treatment with hypericin in A431 human epidermoid carcinoma cells. J. Environ. Pathol. Toxicol. Oncol. 2006, 25, 173-188.
92. Theodossiou, T.A.; Noronha-Dutra, A.; Hothersall, J.S. Mitochondria are a primary target of hypericin phototoxicity: Synergy of intracellular calcium mobilisation in cell killing. Int. J. Biochem. Cell Biol. 2006, 38, 1946-1956.
93. 2+ signaling during hypericin-induced photodynamic therapy (PDT). Med. Laser Appl. 2006, 21, 61-66.
94. Buytaert, E.; Callewaert, G.; Hendrickx, N.; Scorrano, L.; Hartmann, D.; Missiaen, L.; Vandenheede, J.R; Heirman, I.; Grooten, J.; Agostinis, P. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J. 2006, 20, 756-758.
95. 2+ stores. J. Biol. Chem. 2002, 277, 9219-9225.
96. Buytaert, E.; Callewaert, G.; Vandenheede, J.R.; Agostinis, P. Deficiency in apoptotic effectors Bax and Bak reveals an autophagic cell death pathway initiated by photodamage to the endoplasmic reticulum. Autophagy 2006, 2, 238-240.
97. Dua, H.Y.; Olivo, M.; Mahendran, R.; Huang, Q.; Shen, H.M.; Ong C.N.; Bay. B.H. Hypericin photoactivation triggers down-regulation of matrix metalloproteinase-9 expression in well-differentiated human nasopharyngeal cancer cells. Cell. Mol. Life Sci. 2007, 64, 979-988.
98. Lewis, T.S.; Shapiro, P.S.; Ahn, N.G. Signal transduction through MAP kinase cascades. Adv. Cancer Res. 1998, 74, 49-139.
99. Kyriakis, J.M. Making the connection: coupling of stressactivated ERK/MAPK (extracellular-signal-regulated kinase/mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses. Biochem. Soc. Symp. 1999, 64, 29-48.
100. Ballif, B.A.; Blenis, J. Molecular mechanisms mediating mammalian mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK cell survival signals. Cell Growth Differ. 2001, 12, 397-408.
101. Raingeaud, J.S.; Gupta, J.S.; Rogers, M.; Dickens, J.; Han, R.; Ulevitch, J.; Davis, R.J. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 1995, 270, 7420-7426.
102. Sen, P.; Chakraborty, P.K.; Raha, S. Activation of p38MAPK by repetitive low-grade oxidative stress leads to prosurvival effects. Biochim. Biophys. Acta 2007, 1773, 367-374.
103. Zarubin, T.; Han, J. Activation and signaling of the p38 MAP kinase pahtway. Cell Res. 2005, 15, 11-18.
104. Assefa, Z.; Vantieghem, A.; Declercq, W.; Vandenabeele, P.; Vandenheede, J.R.; Merlevede, W.; de Witte, P.A.M.; Agostinis, P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem. 1999, 274, 8788-8796.
105. Hendrickx, N.; Volanti, C.; Moens, U.; Seternes, O.M.; de Witte, P.; Vandenheede, J.R.; Piette, J.; Agostinis, P. Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells. J. Biol. Chem. 2003, 278, 52231-52239.
106. Sanovic, R.; Krammer, B.; Grumboeck, S.; Verwanger, T. Time-resolved gene expression profiling of human squamous cell carcinoma cells during the apoptosis process induced by photodynamic treatment with hypericin. Int. J. Oncol. 2009, 35, 921-939.
107. Chan, P.S.; Koon, H..; Wu, Z.G.; Wong, R.N.S.; Lung, M.L.; Chang, C.K.; Mak, N.K. Role of p38 MAPKs in hypericin photodynamic therapy-induced apoptosis of nasopharyngeal carcinoma cells. Photochem. Photobiol. 2009, 85, 1207-1217.
108. Buytaert, E.; Matroule, J.Y.; Durinck, S.; Close, P.; Kocanova, S.; Vandenheede, J.R.; de Witte, P.A.; Piette, J.; Agostinis, P. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 2008, 27, 1916-1929.
109. Hendrickx, N.; Dewaele, M.; Buytaert,E.; Marsboom, G.; Janssens, S.; van Boven, M.; Vandenheede, J.R.; de Witte, P.; Agostinis, P. Targeted inhibition of p38α MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy. Biochem. Biophys. Res. Commun. 2005, 337, 928-935.
110. Bredel, M. Anticancer drug resistance in primary human brain tumors. Brain Res. Rev. 2001, 35, 161-204.
111. Lazo, J.S.; Kuo, S.M.; Woo, E.S.; Pitt, B.R. The protein thiol metallothionein as an antioxidant and protectant against antineoplastic drugs. Chem. Biol. Interact. 1998, 111-112, 255-262.
112. Neumann, C.; Grünert, B.R.; Bednarski, P.J. Nicotinamide adenine dinucleotide phosphateregenerating system coupled to a glutathione-reductase microtiter method for determination of total glutathione concentrations in adherent growing cancer cell lines. Anal. Biochem. 2003, 320, 170-178.
113. Townsend, D.M.; Tew, K.D.; Tapiero, H. The importance of glutathione in human disease. Biomed. Pharmacother. 2003, 57, 145-155.
114. Masella, R.; di Benedetto, R.; Varì, R.; Filesi, C.; Giovannini, C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 2005, 16, 577-586.
115. Fojo, T.; Bate, S. Strategies for reversing drug resistance. Oncogene 2003, 22, 7512-7523.
116. Zhao, Y.; Seefeldt, T.; Chen, W.; Carlson, L.; Stoebner, A.; Hanson, S.; Foll, R.; Matthees, D.P.; Palakurthi, S.; Guan, X. Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation. Free Rad. Biol. Med. 2009, 47, 176-183.
117. Oberdanner, C.B.; Plaetzer, K.; Kiesslich, T.; Krammer, B. Photodynamic treatment with fractionated light decreases production of reactive oxygen species and cytotoxicity in vitro via regeneration of glutathione. Photochem. Photobiol. 2005, 81, 609-613.
118. Karioti, A.; Sorrentino, F.; Gratteri, P.; Rigobello, M.P.; Scutari, G.; Messori, L.; Bindoli, A.; Bergonzi, M.C.; Bilia, A.R. Rapid and efficient purification of hypericin and pseudohypericin and inhibition of thioredoxin reductase. Planta Med. Abstr. 2009, 75, 885.
119. Dabrowski, M.J.; Zebala, D.M.J; Lu, W.D.; Mahajan, S.; Kavanagh, T.J.; Atkins, W.M. Glutathione S-transferase P1-1 expression modulates sensitivity of human kidney 293 cells to photodynamic therapy with hypericin. Arch. Biochem. Biophys. 2006, 449, 94-103.
120. Theodossiou, T.A.; Noronha-Dutra, A.; Hothersall, J.S. Mitochondria are a primary target of hypericin phototoxicity: Synergy of intracellular calcium mobilisation in cell killing. Biochem. Cell Biol. 2006, 38, 1946-1956.
121. Du, H.Y.; Li, Y.; Olivo, M.; Yip, W.C.G.; Bay, B.H. Differential up-regulation of metallothionein isoforms in well-differentiated nasopharyngeal cancer cells in vitro by photoactivated hypericin. Oncol. Rep. 2006, 16, 1397-1402.
122. Lavie, G.; Mandel, M.; Hazan, S.; Barliya,T.; Blank, M.; Grunbaum, A.; Meruelo, D.; Solomon, A. Anti-angiogenic activities of hypericin in vivo: Potential for ophthalmologic applications. Angiogenesis 2005, 8, 35-42.
123. Bhuvaneswari, R.; Gan, Y.Y.Y.; Lucky, S.S.; Chin, W.W.L.; Ali, S.M.; Soo, K.C.; Olivo, M. Molecular profiling of angiogenesis in hypericin mediated photodynamic therapy. Mol. Cancer 2008, 7, 56. Available online: http://www.molecular-cancer.com/content/7/1/56 (accessed on 29 January 2010).
124. Bhuvaneswari, R.; Gan, Y.Y.Y.; Yee, K.K.L.; Soo, K.C.; Olivo, M. Effect of hypericin-mediated photodynamic therapy on the expression of vascular endothelial growth factor in human nasopharyngeal carcinoma. Int. J. Mol. Med. 2007, 20, 421-428.
125. Yee, K.K.L.; Soo, K.C.; Olivo, M. Anti-angiogenic effects of hypericin-photodynamic therapy in combination with Celebrex® in the treatment of human nasopharyngeal carcinoma. Int. J. Mol. Med. 2005, 16, 993-1002.
126. Martinez-Poveda, B.; Quesada, A.R.; Medina, M.A. Hypericin in the dark inhibits key steps of angiogenesis in vitro. Eur. J. Pharmacol. 2005, 516, 97-103.
127. Blank, M.; Lavie, G.; Mandel, M..; Hazan, S.; Orenstein, A.; Meruelo, D.; Keisari, Y. Antimetastatic activity of the photodynamic agent hypericin in the dark. Int. J. Cancer 2004, 111, 596-603.
128. Suzuki, O.; Katsumata, Y.; Oya, M.; Bladt, S.; Wagner H. Inhibition of monoamine oxidase by hypericin. Planta Med. 1984, 50, 272-274.
129. Curle, P.; Kato, G; Hiller, K.O. Neurochemical Studies on Valeriana and Hypericum. Report Nr. 2107; Battelle-Europe: St. John's, Gernany, 1988.
130. Denke, A.; Schneider, W, Elstner F.F. Biochemical activities of extracts from Hypericum perforatum L. 2nd communication: Inhibition of metenkephaline and tyrosine dimerization. Drug Res. 1999, 49, 109-114.
131. Cott, J.M. In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract. Pharmacopsychiatry 1997, 30 (Suppl. 2), 108-112.
132. Butterweck, V.; Bockers, T.; Korte, B.; Wittkowski, W.; Winterhoff, H. Long-term effects of St. John's wort and hypericin on monoamone levels in rat hypothalamus and hippocampus. Brain Res. 2002, 930, 21-29.
133. Obry, T. Einfluβ eines ethanolischen Auszuges aus Hypericum perforatum auf die Enzyme der Noradrenalinsynthese und auf die Diaphorase [diploma work]. Maximilians-Universität: München, Germany, 1991.
134. Kleber, E.; Obry, T.; Hippeli, S.; Schneider, W.; Elstner E.F. Biochemical activity of extracts from Hypericum perforatum L. 1st communication: Inhibition of dopamine-beta-hydroxylase. Drug Res. 1999, 49, 106-109.
135. Butterweck, V.; Korte, B.; Winterhoff H. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment. Pharmacopsychiatry 2001, 34 (Suppl. 1), 2-7.
136. Butterweck, V.; Winterhoff, H.; Herkenham, M. St. John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and longterm administration in normal and stressed rats. Mol. Psychiatry 2001, 6, 547-564.
137. Simmen, U.; Bobirnac, I.; Ullmer, C.; Lübbert, H.; Berger Büter, K.; Schaffner, W.; Schoeffter, P. Antagonist effect of pseudohypericin at CRF1 receptors. Eur. J. Pharmacol. 2003, 458, 251-256.
138. Wang, X.; Liu, Z.; Jiang, H.; Liu, L.; Lan, A. Inhibitory effect of monomeric hypericin on human cytomegalovirus in vitro. J. Wuhan Univ.: Med. Ed. 2006, 27, 303-306.
139. Wang, S.Y.; Chen, J.H.; Liang, J.P.; Cui, Y.; Shang, R.F.; Wang, X.H.; Hua, L.Y. Studies on the inhibitory effects of hypericin on the adsorption ability of foot-and-mouth virus to host cells in vitro. J. Chin. Vet. Med. 2009, 28, 5-8.
140. Pu, X.; Liang, J.; Xu, T.; Shang, R.; Wang, X.; Hua, L.; Liu, Y.; Xing, Y. Study on the activity in vitro of hypericin against highly pathogenic porcine reproductive and respiratory syndrome virus. Chin. J. Vet. Sci. 2008, 38, 810-815.
141. Naesens, L.; Bonnafous, P.; Agut, H.; De Clercq, E. Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J. Clin. Virol. 2006, 37, S69-S75.
142. Hu, D.H.; Gao, Y.; Shao, C.; Feng, Q.K.; Wang, R. Study on hypericin in Hypericum perforatum L and its interactions with human immunodeficiency virus-1 reverse transcriptase. J. Mol. Sci. 2008, 24, 280-283.
143. Qu, X.B.; Su, Z.M.; Hu, D.H.; Bao, Y.L.; Meng, X.Y.; Wu, Yin; Li, Y.X. Studies on molecular structure of hypericin and its interactions with HIV-1 protease. By molecular modeling. Chem. J. Chin. Univ. 2009, 30, 1402-1405.
144. Di Carlo, G.; Borrelli, F.; Ernst, E; Izzo, A.A. St. John's wort. Prozac from the plant kingdom. Trends Pharmacol. Sci. 2001, 2, 292-297.
145. Conforti, F.; Statti, G. A.; Tundis, R.; Bianchi, A.; Agrimonti, C.; Sacchetti, G.; Andreotti, E.; Menichini, F.; Poli, F. Comparative chemical composition and variability of biological activity of methanolic extracts from Hypericum perforatum L. Nat. Prod. Res. 2005, 19, 295-303.
146. Cecchini, C.; Cresci, A.; Coman, M.M.; Ricciutelli, M.; Sagratini, G.; Vittori, S.; Lucarini, D.; Maggi, F. Antimicrobial activity of seven Hypericum entities from central Italy. Planta Med. 2007, 73, 564-566.
147. Pistelli, L.; Bertoli, A.; Morelli, I.; Menichini, F.; Musmanno, R.A.; Di Maggio, T.; Coratza, G. Chemical and antibacterial evaluation of Hypericum triquetrifolium Turra. Phytother. Res. 2005, 19, 787-791.
148. Higuchi, A.; Yamada, H.; Yamada, E.; Jo, N.; Matsumura, M. Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy. Mol. Vision 2008, 14, 249-254.
149. Hammer, K.D.P.; Hillwig, M.L.; Solco, A.K.S.; Dixon, P.M.; Delate, K.; Murphy, P.A.; Wurtele E.S.; Birt, D.F. Inhibition of Prostaglandin E2 production by anti-inflammatory Hypericum perforatum extracts and constituents in RAW264.7 mouse macrophage cells. J. Agric. Food. Chem. 2007, 55, 7323-7331.
150. Sosa, S.; Pace, R.; Bornancin, A.; Morazzoni, P.; Riva, A.; Tubaro, A.; Della Loggia, R. Topical anti-inflammatory activity of extracts and compounds from Hypericum perforatum L. J. Pharm. Pharmacol. 2007, 59, 703-709.
151. Sgarbossa, A.; Buselli, D.; Francesco Lenci, F. In vitro perturbation of aggregation processes in b-amyloid peptides: A spectroscopic study. FEBS Lett. 2008, 582, 3288-3292.
152. Kraus, B.; Wolff, H.; Heilmann, J.; Elstner, E.F. Influence of Hypericum perforatum extract and its single compounds on amyloid-β mediated toxicity in microglial cells. Life Sci. 2007, 81, 884-894.
153. Stupakova, V.; Varinska, L.; Mirossay, A.; Sarissky, M.; Mojzis, J.; Dankovcik, R.; Urdzik, P.; Ostro, A.; Mirossay, L. Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines. Phytother. Res. 2009, 23, 827-832.
154. Wang, X.; Zhang, J.; Liu, J.; Yang, R. Photocytotoxic effect of hypericin and extract in Hypericum perforatum L. on HepG2 cancer cell line of human liver in vitro. J. Chin. Integr. Med. 2008, 19, 69-71.
155. Seitz, G.; Krause, R.; Fuchs, J.; Heitmann, H.; Armeanu, S.; Ruck, P.; Warmann, S.W. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin. Oncol. Rep. 2008, 20, 1277-1282.
156. Wang, X.; Liu, J.; Zhang, J.; Yang, R. Killing effects of hypericin and extracts from hypericin on SpcA 1 lung cancer cell lines of human in vitro. Chin. Pharmaceut. J. 2008, 17, 13-15.
157. Wang, X.; Zhang, J.; Liu, J.; Yang, R. In vitro damage effects of hypericin extract from Hypericum perforatum on human lung cancer cells A549. Chin. Tradit. Patent Med. 2007, 29, 1058-1061.
158. Wang, X.; Zhang, J.; Liu, J.; Yang, R. Photocytotoxic effect of hypericin extract from Hypericum perforatum L. on MDA231 human mammary carcinoma cell lines in vitro. Chin. J. Morden Appl. Pharm. 2008, 25, 1-4.
159. Wessels, J.T.; Busse, A.C.; Rave-Fraenk, M.; Zaenker, S.; Hermann, R.; Grabbe, E.; Mueller, G.A. Photosensitizing and radiosensitizing effects of hypericin on human renal carcinoma cells in vitro. Photochem. Photobiol. 2008, 84, 228-235.
160. Seitz, G.; Warmann, S.W.; Armeanu, S.; Heitmann, H.; Ruck, P.; Hoffman, R.M.; Fuchs, J.; Wessels, J.T. In vitro photodynamic therapy of childhood rhabdomyosarcoma. Int. J. Oncol. 2007, 30, 615-620.